Overview

Iloprost in High Risk Cardiac Surgical Patients

Status:
Completed

Trial end date:
2012-03-01

Target enrollment:

Participant gender:

Summary

In this study effects of the intra operative, prophylactic inhalation of Iloprost (Ventavis) before and during extracorporal circulation on perioperative morbidity and outcome in high risk cardiac surgical patients is investigated in comparison to placebo.

Phase:

Phase 3

Details

Lead Sponsor:

Ludwig-Maximilians - University of Munich

Collaborator:

Algora

Treatments:

Iloprost